GSK’s Meningitis Vaccine Should Be Limited To High-Risk Children, CDC Panel Advises
This article was originally published in The Pink Sheet Daily
Executive Summary
The Advisory Committee on Immunization Practices voted to recommend restricting use of GSK’s MenHibrix given the low incidence of meningococcal disease in infants and toddlers and the fact the vaccine does not protect against the most common strain of the disease.